Patent Assignment
Reel/Frame 014438/0001
Nunc Pro Tunc Assignment
Recorded: 2004-03-17
Pages: 3
Assignee
HAEMACURE CORPORATION
2001 UNIVERSITY, SUITE 430, MONTREAL, QUEBEC, H3A 2A6, CANADA
Covered Property
(1)
Therapeutic Grade Thrombin Produced by Chromatography
Patent:
5,506,127 →
Application:
08/309,583 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Jun 1, 2009
From: HAEMACURE CORPORATION (A CANADIAN CORPORATION); HAEMACURE CORPORATION (A DELAWARE CORPORATION)
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 022757/0858 →
Assignment of Assignor's Interest
Apr 27, 2010
From: HAEMACURE CORPORATION
To: ANGIOTECH FLORIDA HOLDINGS, INC.
Reel/Frame 024294/0678 →
Patent Security Agreement
Jun 16, 2010
From: ANGIOTECH FLORIDA HOLDINGS, INC.
To: WELLS FARGO CAPITAL FINANCE, LLC (F/K/A WELLS FARGO FOOTHILL, LLC), AS AGENT
Reel/Frame 024546/0524 →
Assignment of Assignor's Interest
Oct 3, 2011
From: ANGIOTECH FLORIDA HOLDINGS, INC.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 027006/0431 →
Release of Security Interest
Apr 15, 2013
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.
Reel/Frame 030218/0820 →